** 3M MMM.N raised its full-year profit forecast and projected a smaller tariff-related hit to its 2025 earnings on Friday
** Median PT of 19 brokerages covering the stock is $170 - LSEG data
ROOM FOR BULLS AND BEARS
** Morgan Stanley ("underweight," PT: $125) believes the sharp reversal in MMM stock is justified, as despite the earnings beat the outlook for second-half growth appears weak due to limited pricing power, potential volume headwinds and rising trade policy risks
** Barclays ("overweight," PT: $172) says "We think MMM's results all-in were encouraging, both on capital deployment (larger buyback) and the margin performance despite tariffs"
** Wolfe Research ("outperform," PT: $187) views 3M's stock drop as a buying opportunity, citing strong earnings, raised guidance, and conservative margin forecasts despite no clear reason for the negative market reaction
** Morningstar (fair value: $101) says "Although the firm shows signs of life, we expect litigation and secular declines in a number of its businesses to hamper results for quite some time"
(Reporting by Rashika Singh in Bengaluru)
((rashika.singh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.